HLA-B*5701 genotype is a major determinant of drug-induced liver injury due to flucloxacillin
Nature Genetics2009Vol. 41(7), pp. 816–819
Citations Over TimeTop 1% of 2009 papers
for the DILIGEN study, Ann K. Daly, Peter T. Donaldson, Pallav Bhatnagar, Yufeng Shen, Itsik Pe’er, Aris Floratos, Mark J. Daly, David B. Goldstein, Sally John, Matthew R. Nelson, Julia Graham, B. Kevin Park, John Dillon, William Bernal, Heather J. Cordell, Munir Pirmohamed, Guruprasad P. Aithal, Christopher P. Day
Related Papers
- → Flucloxacillin-induced liver injury(2008)35 cited
- → Prolonged hepatic cholestasis after flucloxacillin therapy(1989)55 cited
- → Linkage disequilibrium and haplotypes of the rs1042522, rs1625895, and rs1787862 markers of TP53 in patients with diffuse large B-cell lymphoma(2014)6 cited
- → P080 Potential taste disturbance is largely mild and diminishes with continuing treatment in cystic fibrosis patients treated with levofloxacin inhaled solution(2018)4 cited
- Flucloxacillin and hepatic injury(1996)